Summit Therapeutics
SMMT
SMMT
237 hedge funds and large institutions have $2.08B invested in Summit Therapeutics in 2025 Q2 according to their latest regulatory filings, with 73 funds opening new positions, 66 increasing their positions, 74 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
10% more capital invested
Capital invested by funds: $1.89B → $2.08B (+$193M)
0.07% less ownership
Funds ownership: 13.25% → 13.18% (-0.07%)
11% less repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 74
Holders
237
Holding in Top 10
4
Calls
$126M
Puts
$77.1M
Top Buyers
| 1 | +$198M | |
| 2 | +$23.2M | |
| 3 | +$21.3M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$17.7M |
| 5 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$16.7M |
Top Sellers
| 1 | -$63.1M | |
| 2 | -$56.4M | |
| 3 | -$33M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$32.9M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$22.7M |
